$5.51 -0.09 (-1.61%)
12/3/2009 4:00 PM

Maxygen, Inc. (MAXY)

CAPS Rating: 2 out of 5

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Recs

0
Member Avatar Dublin063 (92.40) Submitted: 6/13/2008 3:11:43 PM : Underperform Start Price: $3.54 MAXY Score: -71.32

A biotechnology company committed to the discovery and development of improved next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

Report this Post 0 Comments

Featured Broker Partners